Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Syk and tired of current chronic GVHD therapies.Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation.Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host DiseasePresence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy.Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.Emerging drugs for graft-versus-host disease.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Mechanistic approaches for the prevention and treatment of chronic GVHD.Novel targets in the treatment of chronic graft-versus-host disease.Recent advances in hematopoietic stem cell transplantation.Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.Central role of PI3K-SYK interaction in fibrinogen-induced lamellipodia and filopodia formation in platelets.Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.New and emerging therapies for acute and chronic graft versus host disease.B-cell targeting in chronic Graft-versus-Host disease.Cytokine mediators of chronic graft-versus-host disease.Biomarkers for post-transplantation outcomes.The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHDHuman CARD9: A Critical Molecule of Fungal Immune Surveillance
P2860
Q28076264-1D7DF4FB-359A-4DBE-B8A1-F6E6CDF9022CQ33798102-369E96C6-A3AD-4F16-8059-A642E1CB1236Q35784487-70D6AEA6-CD35-4A3F-B48B-F293CD9A9775Q36130498-78520442-1A95-4F9E-A1AC-93001FCD2036Q36220062-BA5BBB5E-632E-4E33-BF17-2416B233FDFFQ36358880-0FC35745-EA89-4111-A1D2-1DACD986F301Q36851405-9AF113B6-2470-42FB-9193-550C550B465FQ37035815-899B8C46-C1D2-4482-8D76-FFF3160D7B57Q38405199-1F7ED579-9BE7-4DD1-987D-35DF0120821BQ38656329-71F51BB9-B6E0-456C-9EC6-BD33A0A5F8F6Q38786084-A6985054-B345-4610-8DB3-E1C6114A3EB5Q39002164-67040A7E-523E-4A00-9D2D-58D01BFD8F0EQ39002166-4A0D93D1-FD39-4CD4-9E4A-7B7CFA6958BDQ39023963-4E507047-3182-4837-B54C-4C56667FBF7FQ39405882-E80093BA-B673-40C2-A512-DE018AE382E8Q41563521-D150E729-7295-464C-8D6A-E4D488368BD2Q41779379-6B028B0D-64B8-4BF9-830C-D63DF06DAB56Q42737499-FFBB2DDB-E6A1-401B-BD99-E4AB75AE2AFCQ47709978-2FE8F1D9-3C2F-45AF-B107-B63C4DB53E87Q49238507-7C48A966-550E-4617-80B5-808682B17DDEQ50044417-57E13D14-641F-495F-8CCC-EB96C1594B0EQ50915048-4F307485-415E-4DA9-B7B2-8C161EB1DB21Q52603913-E82A114C-FFC3-48BE-8175-6BC7FD8485D9Q52971841-8AA9A157-FF84-44CC-B29A-177326E5A1D2Q54979506-E8606900-8B14-4188-AB3B-882DC37982ECQ55045366-6CDCB120-0FD5-4FDF-9C1F-0325E5B60A41Q58723868-A8BAED41-2BC3-49CC-A10F-0D156364442CQ58799049-8C37C681-3DBC-478C-80C5-83C197EFD17F
P2860
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@ast
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@en
type
label
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@ast
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@en
prefLabel
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@ast
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@en
P2093
P2860
P50
P1433
P1476
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease.
@en
P2093
Ante Vulic
Corey S Cutler
Ivan Maillard
Jessica L Allen
John Koreth
Jonathan C Poe
Joseph H Antin
Katelyn Paz
Kylie A Alexander
P2860
P304
P356
10.1182/BLOOD-2014-08-595470
P407
P50
P577
2015-04-07T00:00:00Z